Health
Novel microfluidic approach to fight cancer could greatly benefit patients – News-Medical.Net
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technolo…
Reviewed by Emily Henderson, B.Sc.Oct 20 2020
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to “purify” the immune cells of patients in the fight against cancer.
UniSA’s Future Industries Institute PhD student Mona Elsemary has developed a microfluidic approach to purify chimeric antigen receptor (CAR-T) cells, the bioengineered immune cells that are the basis of groundbreaking …
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News20 hours agoSudden death investigation, Maroochydore – Sunshine Coast